Development of High-Value-Added New Materials and Applications
First written in FY2016. 25 of 31 entries say "Restated". Latest entry: FY2026.
22 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「R&D expenses for the fiscal year ending 31 March 2026 were ¥775 million. R&D activities during the fiscal year produced the following results.」
The company recorded ¥775 million in R&D expenses and described development results for oiling agents, sizing agents, scouring agents, antistatic agents, new cleaning agents, emulsifiers, cement additives, high-performance antifogging agents, and rubber anti-tack agents and release agents for nonwoven fabrics, carbon fibers, spandex and polyester industrial materials. - FY2026-H1RestatedAnnual report
「R&D expenses for the six-month interim period of the current fiscal year were ¥397 million.」
R&D activities continued, with R&D expenses for the six-month interim period of the current fiscal year reaching ¥397 million. - FY2025RestatedAnnual report
「R&D activities during the fiscal year produced the following results.」
The company recorded ¥798 million in R&D expenses and described development results for oiling agents, sizing agents, scouring agents, antistatic agents, new cleaning agents, defoamers, cement additives, high-performance antifogging agents, and rubber anti-tack agents and release agents for nonwoven fabrics, carbon fibers and spandex. - FY2024AdvancedAnnual report
「R&D expenses for the fiscal year ended 31 March 2024 were ¥803 million. R&D activities during the fiscal year produced the following results.」
The company recorded ¥803 million in R&D expenses and described development results for oiling agents, sizing agents, scouring agents, antistatic agents, new cleaning agents, defoamers, cement additives, high-performance antifogging agents, and rubber anti-tack agents and release agents for nonwoven fabrics, carbon fibers, spandex and polyester industrial materials. - FY2024-Q3RestatedAnnual report
「R&D expenses for the nine-month period of the current fiscal year were ¥633 million.」
R&D activities continued, with R&D expenses for the nine-month period of the current fiscal year reaching ¥633 million. - FY2024-Q2RestatedAnnual report
「R&D expenses for the six-month period of the current fiscal year were ¥426 million.」
R&D activities continued, with R&D expenses for the six-month period of the current fiscal year reaching ¥426 million. - FY2024-Q1RestatedAnnual report
「R&D expenses for the three-month period of the current fiscal year were ¥215 million.」
R&D activities continued, with R&D expenses for the three-month period of the current fiscal year reaching ¥215 million. - FY2023-Q3RestatedAnnual report
「R&D expenses for the nine-month period of the current fiscal year were ¥594 million.」
R&D activities continued, with R&D expenses for the nine-month period of the current fiscal year reaching ¥594 million. - FY2023-Q2RestatedAnnual report
「R&D expenses for the six-month period of the current fiscal year were ¥395 million.」
R&D activities continued, with R&D expenses for the six-month period of the current fiscal year reaching ¥395 million. - FY2023-Q1RestatedAnnual report
「R&D expenses for the three-month period of the current fiscal year were ¥188 million.」
R&D activities continued, with R&D expenses for the three-month period of the current fiscal year reaching ¥188 million. - FY2022AdvancedAnnual report
「R&D expenses for the fiscal year ended 31 March 2022 were ¥771 million.」
The company recorded ¥771 million in R&D expenses and listed development results for oiling agents, sizing agents, scouring agents, antistatic agents, new cleaning agents, defoamers, new cement additives, high-performance antifogging agents, and rubber anti-tack agents and release agents for nonwoven fabrics, carbon fibers, spandex and polyester industrial materials. - FY2022-Q3RestatedAnnual report
「R&D expenses for the nine-month period of the current fiscal year were ¥581 million.」
R&D activities continued, with R&D expenses for the nine-month period of the current fiscal year reaching ¥581 million. - FY2022-Q2RestatedAnnual report
「R&D expenses for the six-month period of the current fiscal year were ¥387 million.」
R&D activities continued, with R&D expenses for the six-month period of the current fiscal year reaching ¥387 million. - FY2022-Q1RestatedAnnual report
「R&D expenses for the three-month period of the current fiscal year were ¥190 million.」
R&D continued, with R&D expenses for the three-month period of the current fiscal year reaching ¥190 million. - FY2021AdvancedAnnual report
「R&D expenses for the fiscal year ended 31 March 2021 were ¥783 million. R&D activities during the fiscal year produced the following results.」
The company recorded ¥783 million in R&D expenses and listed development results for oiling agents, sizing agents, scouring agents, antistatic agents, new cleaning agents, defoamers, cement additives, high-performance antifogging agents, rubber anti-tack agents and release agents for nonwoven fabrics, carbon fibers, spandex and polyester industrial materials. - FY2021-Q3RestatedAnnual report
「R&D expenses for the nine-month period of the current fiscal year were ¥598 million.」
R&D continued, with total R&D expenses for the nine-month period of the current fiscal year reaching ¥598 million. - FY2020-Q3RestatedAnnual report
「R&D expenses for the nine-month period of the current fiscal year were ¥583 million.」
R&D continued, with total R&D expenses for the nine-month period of the current fiscal year reaching ¥583 million. - FY2020-Q2RestatedAnnual report
「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥389 million.」
The company continued its research and development activities, with total research and development expenses for the six-month period of the current consolidated fiscal year amounting to ¥389 million. - FY2020-Q1RestatedAnnual report
「Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥195 million.」
The company continued its research and development activities, with total research and development expenses for the three-month period of the current consolidated fiscal year amounting to ¥195 million. - FY2019AdvancedAnnual report
「Research and development expenses for the consolidated fiscal year (1 April 2018 to 31 March 2019) were ¥770 million. The company's research and development activities during the consolidated fiscal year produced the following results.」
The company recorded ¥770 million in research and development expenses and listed development results including sizing agents for nonwoven fabrics, carbon fiber, spandex and polyester industrial materials; sizing agents for AJL and WJL; and new cleaning agents, defoamers, cement additives and antifogging agents. - FY2019-Q3RestatedAnnual report
「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥585 million.」
The company continued its research and development activities, with total research and development expenses for the nine-month period of the current consolidated fiscal year amounting to ¥585 million. - FY2019-Q2RestatedAnnual report
「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥392 million.」
The company continued its research and development activities, with total research and development expenses for the six-month period of the current consolidated fiscal year amounting to ¥392 million. - FY2019-Q1RestatedAnnual report
「The company is working on research, development and manufacturing with its extensive staff in order to quickly identify the increasingly diverse needs of its business partners and customers and provide products that create new value. Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥200 million.」
The company continues research, development and manufacturing of products that address customer needs and create new value, with research and development expenses for the quarter amounting to ¥200 million. - FY2018AdvancedAnnual report
「Research and development expenses for the consolidated fiscal year (1 April 2017 to 31 March 2018) were ¥809 million. The company's research and development activities during the consolidated fiscal year produced the following results.」
The company recorded ¥809 million in research and development expenses and listed development results including sizing agents for nonwoven fabrics, carbon fiber and spandex; sizing agents for WJL; and new cleaning agents, defoamers, cement additives and antifogging agents. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥611 million.」
The company continued its research and development activities, with total research and development expenses for the nine-month period of the current consolidated fiscal year amounting to ¥611 million. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥411 million.」
The company continued its research and development activities, with total research and development expenses for the six-month period of the current consolidated fiscal year amounting to ¥411 million. - FY2018-Q1RestatedAnnual report
「The company established its current position by developing proprietary technologies not only in the surfactants field but also in the polymer field. Going forward, it will seek to expand its overseas customer base and strengthen its ability to respond to the global economy by further enhancing its technological development capabilities.」
The company continues technological development in the surfactants and polymers fields. Total research and development expenses for the three-month period of the current consolidated fiscal year were ¥206 million. - FY2017-Q3RestatedAnnual report
「As expressed in its corporate motto, "Satisfaction for customers through quality products at reasonable prices," the company is working on research, development and manufacturing with its extensive staff in order to quickly identify the increasingly diverse needs of its business partners and customers and provide products that create new value.」
The company continues research, development and manufacturing of products that address customer needs and create new value. Total research and development expenses for the nine-month period of the current consolidated fiscal year were ¥620 million. - FY2017-Q2RestatedAnnual report
「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥414 million.」
The company continued its research and development activities, with total research and development expenses for the six-month period of the current consolidated fiscal year amounting to ¥414 million. - FY2017-Q1RestatedAnnual report
「The company is working on research, development and manufacturing with its extensive staff in order to quickly identify the increasingly diverse needs of its business partners and customers and provide products that create new value.」
The company continues research, development and manufacturing of products that address customer needs and create new value. Total research and development expenses for the quarter were ¥209 million. - FY2016First statedAnnual report
「In research and development, we are developing new materials and applications with higher added value, while continuing to operate our businesses flexibly and deploy resources where they are most appropriate in response to changes in social conditions. R&D expenses for the fiscal year ended March 2016 were ¥806 million.」
The company develops new materials and applications in multiple fields, including textiles, cosmetics, construction materials and cement, resin films and rubber, based on interfacial science and polymer chemistry.